Immunosuppression Could Influence De Novo Angiotensin II Type Receptor Antibodies Development Early After Kidney Transplantation

被引：0
|
作者：
Sorohan, Bogdan M. [1 ,2 ]
Berechet, Andreea Ioana [2 ]
Bucsa, Cristina [2 ]
Tincu, Corina [2 ]
Obrisca, Bogdan [1 ,2 ]
Ismail, Gener [1 ,2 ]
机构：
[1] Univ Med Farm Carol Davila, Bucharest, Romania
[2] Inst Clin Fundeni, Bucharest, Romania
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO2198
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [1] Immunosuppression as a Risk Factor for De Novo Angiotensin II Type Receptor Antibodies Development after Kidney Transplantation
    Sorohan, Bogdan Marian
    Sinescu, Ioanel
    Tacu, Dorina
    Bucsa, Cristina
    Tincu, Corina
    Obrisca, Bogdan
    Berechet, Andreea
    Constantinescu, Ileana
    Maruntelu, Ion
    Ismail, Gener
    Baston, Citalin
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [2] De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children
    Hesemann, Laura E.
    Subramanian, Vijay
    Mohanakumar, Thalachallour
    Dharnidharka, Vikas R.
    PEDIATRIC TRANSPLANTATION, 2015, 19 (05) : 499 - 503
  • [3] Angiotensin Ii Type 1 Receptor Antibodies In Childhood Kidney Transplantation
    Bjerre, Anna
    Tangeraas, Trine
    Dechend, Ralph
    Heidecke, Harald
    Staff, Anne Cathrine
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1682 - 1682
  • [4] Angiotensin II type 1 receptor antibodies in childhood kidney transplantation
    Bjerre, Anna
    Tangeraas, Trine
    Heidecke, Harald
    Dragun, Duska
    Dechend, Ralf
    Staff, Anne Cathrine
    PEDIATRIC TRANSPLANTATION, 2016, 20 (05) : 627 - 632
  • [5] Efficacy of equoral in prophylactic immunosuppression after de novo kidney transplantation
    Zadrazil, Josef
    Al Jabry, Sadek
    Horak, Pavel
    Bachleda, Petr
    Gibejova, Agata
    Kamarad, Vojtech
    DIALYSIS & TRANSPLANTATION, 2007, 36 (11) : 602 - +
  • [6] Athena - Effect of Primary Immunosuppression on Development of De Novo Donor Specific Antibodies within First Year After Kidney Transplantation
    Arns, W.
    Philippe, A.
    Ditt, V.
    Hauser, I. A.
    Thaiss, F.
    Sommerer, C.
    Suwelack, B.
    Finkel, A.
    Schiedel, C.
    Dragun, D.
    Nashan, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 498 - 498
  • [7] Early De Novo malignancies after kidney transplantation
    Veroux, M
    Puliatti, C
    Fiamingo, P
    Cappello, D
    Macarone, M
    Puliatti, D
    Vizcarra, I
    Gagliano, M
    Veroux, P
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) : 718 - 720
  • [8] Early immunosuppression treatment correlates with later de novo donor-specific antibody development after kidney and pancreas transplantation
    Pelletier, Ronald P.
    Rajab, Amer A.
    Diez, Alejandro
    DiPaola, Nicholas R.
    Bumgardner, Ginny L.
    Elkhammas, Elmahdi A.
    Henry, Mitchell L.
    CLINICAL TRANSPLANTATION, 2015, 29 (12) : 1119 - 1127
  • [9] THE ROLE OF PRIMARY DISEASE FOR THE DEVELOPMENT OF DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION
    Lionaki, Sophia
    Drouzas, Konstantinos
    Pappas, Apostolos
    Kapsia, Helen
    Altanis, Nikolaos
    Liapis, George
    Iniotaki, Alice
    Zavos, George
    Boletis, John
    TRANSPLANT INTERNATIONAL, 2015, 28 : 358 - 358
  • [10] Association between the development of anti-angiotensin II type-1 receptor antibodies and hypertension in kidney transplantation
    Davila-Radilla, F.
    Orea-Tejeda, AArturo
    Alberu-Gomez, J.
    Castillo-Martinez, L.
    Hernandez-Mendez, A.
    Alcala-Davila, E.
    Salcedo, M. I.
    Hernandez-Izelo, A.
    Vilatoba, M.
    Calvario-Mayorga, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 295 - 296
12345